Motivational interviewing to improve self-efficacy and quality of life in pregnant women with gestational diabetes
The Effect of Motivational Interviewing on Health Management Self-Efficacy and Quality of Life in Pregnants With Gestational Diabetes Mellitus
This study is testing if motivational interviews can help pregnant women with gestational diabetes feel more confident in managing their health and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Cukurova University Academic / other |
| Locations | 1 site (Adana, Sarıçam) |
| Trial ID | NCT06243939 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of motivational interviewing on health management self-efficacy and quality of life among pregnant women diagnosed with gestational diabetes mellitus. Conducted as a randomized controlled trial, it involves a series of motivational interviews over four weeks with participants who are in their 24-28 weeks of pregnancy. Assessments using the Health Management Self-Efficacy Scale and Quality of Life Scale will be conducted before and after the intervention to measure outcomes. The goal is to enhance the participants' ability to manage their health and improve their overall quality of life during pregnancy.
Who should consider this trial
Good fit: Ideal candidates are first-time pregnant women between 24-28 weeks gestation who have been diagnosed with gestational diabetes mellitus.
Not a fit: Patients with pre-existing diabetes, chronic diseases, or significant psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the self-efficacy and quality of life for pregnant women managing gestational diabetes.
How similar studies have performed: Previous studies have shown that motivational interviewing can effectively improve self-efficacy and health outcomes in various populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Being pregnant for the first time * Being diagnosed with gestational diabetes mellitus * 24-28. Being in the pregnancy week * Being able to speak and understand Turkish * Being 18 years or older * Having a single and viable fetus * Volunteering to participate in research * Having and being able to use a mobile phone * Having all check-ups at the same hospital and regularly throughout pregnancy, Exclusion Criteria: * Being diagnosed with diabetes mellitus (type 1, type 2 diabetes) before pregnancy * Having a psychiatric diagnosis, * Having a chronic disease * Having risk factors such as threat of premature birth, placenta previa, premature rupture of membranes * Having any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish), * Pregnant women who do not want to continue the study and give birth before the 37th week of pregnancy will be excluded from the study.
Where this trial is running
Adana, Sarıçam
- Meltem Akbaş — Adana, Sarıçam, Turkey (Recruiting)
Study contacts
- Principal investigator: Meltem Akbaş, PhD — Universty Of Cukurova
- Study coordinator: Meltem Akbaş, PhD
- Email: makbaskanat@gmail.com
- Phone: +905065146780
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.